BioAtla, Inc. (BCAB): Price and Financial Metrics
BCAB Price/Volume Stats
| Current price | $0.69 | 52-week high | $4.02 |
| Prev. close | $1.19 | 52-week low | $0.67 |
| Day low | $0.67 | Volume | 6,247,500 |
| Day high | $1.08 | Avg. volume | 863,569 |
| 50-day MA | $1.75 | Dividend yield | N/A |
| 200-day MA | $2.00 | Market Cap | 33.47M |
BCAB Stock Price Chart Interactive Chart >
BioAtla, Inc. (BCAB) Company Bio
BioAtla LLC develops conditionally active biologic antibody therapeutics. The firm's technologies include conditionally active biologics, comprehensive integrated antibody optimization, CPE and CPS, gigamab, and versitop. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
BCAB Price Returns
| 1-mo | -50.36% |
| 3-mo | -59.88% |
| 6-mo | -55.77% |
| 1-year | -69.06% |
| 3-year | -96.46% |
| 5-year | N/A |
| YTD | -71.95% |
| 2023 | -70.18% |
| 2022 | -57.97% |
| 2021 | -42.28% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...